ArticleEye (London, England)2025
Tear proteomics reveals expressed proteins and potential pathways associated with diabetic keratopathy.
Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPatients with diabetes are at risk of developing diabetic keratopathy (DK). The pathophysiological mechanisms of DK and associated biomarkers remain unclear. However, tear analysis provides crucial insights into DK. Thus, we conducted a quantitative proteomic analysis of tears from DK patients to identify differentially expressed proteins and potential pathways associated with DK.
methodsThis prospective case-controlled study included patients admitted to Zhujiang Hospital between October 2022 and February 2023. We examined 22 eyes with DK and 11 control eyes without DK. General characteristics and dry eye-related features were recorded, including those observed using ocular surface analysis, conjunctival impression cytology, and tear ferning tests. Tear fluid was collected using Schirmer strips after ensuring group similarity in confounders. Proteins were analysed through four-dimensional label-free mass spectrometry. Differential proteins were subjected to analyses of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. A protein-protein interaction network map was constructed.
resultsOf the 2733 proteins identified, 313 (156 upregulated and 157 downregulated) differentially expressed proteins were screened. GO analysis revealed that these differentially expressed proteins mainly participated in mRNA decay, nuclear transcription, and receptor-mediated endocytosis. KEGG analysis showed that these differentially expressed proteins could be involved in pathways, such as arginine biosynthesis, extracellular matrix-receptor interactions.
conclusionsArginine biosynthesis and extracellular matrix-receptor interactions may be involved in DK pathogenesis, and VDAC3 may be a potential biomarker for DK. These findings would enhance the understanding of DK among ophthalmologists as well as help in developing novel strategies for its treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.